CODHy 2026’s Program
2026 PROGRAM
May 22 Friday 2026
| 08:00-09:40 | Plenary Session 1: Opening Session Chairs: TBD 08:00-08:10 Chairs Opening Speech Ning Guang (China), Itamar Raz (Israel), Antonio Ceriello (Italy) 08:10-08:40 Opening Ceremony Opening Report Chairs: TBD 08:40-09:00 TBD Itamar Raz (Israel) 09:00 -09:20 TBD: Ning Guang (China) 09:20 -09:40 Diabetes Management in Minorities |
| 09:40-12:00 | Plenary Session 2: Keynote Session Chairs: TBD 09:40-10:00 News on Hypertension and Diabetes 10:00-10:20 Environment and Diabetes—Antonio Ceriello (Italy) 10:20-10:50 Beta cell’s role in the pathogenesis and treatment of prediabetes and type 2 diabetes 10:50-11:30 Discussion and Photo 11:30-12:00 Hall turnover and Lunch box Pickup |
| HALL A | HALL B | HALL C | |
| 12:00-14:00 | Lunch Symposium A | Lunch Symposium B | Lunch Symposium C |
| 14:00-16:00 | Session 1| Future Technologies and Treatments Chairs: Automating insulin delivery through pump and continuous glucose monitoring connectivity: Maximizing opportunities to improve outcomes 20min The use of continuous glucose monitoring in people living with obesity, intermediate hyperglycemia or type 2 diabetes 20min What should be the best therapeutic choice for the early treatment of type 2 diabetes? 20min Strategy to improve the therapy adherence: are the prefixed combinations the solution? 20min Discussion 40min | Session 2| Cardio-renal disease in type 2 diabetes Chairs: How cardiologists can manage excess body weight and related cardiovascular risk 20min How diabetologists can manage excess body weight and related cardiovascular risk 20 min The link between heart failure and kidney disease: how to face in diabetes? A cardiologist point of view 20min Nephrologist point of view 20min Discussion 40min | Session 3|Diabetic foot Chairs: Overview on world diabetic foot issue 20min The Chinese situation of diabetic foot 20min Prevention of diabetic foot 20min New theraputic strategies for diabetic foot management 20 min Discussion 40min |
| 16:00-18:00 | Session 4| Cardio-renal disease in type 1 diabetes Chairs: CVD in type 1 diabetes 20min CKD in type 1 diabetes 20min Markers of cardio-renal disease in type 1 diabetes 20 min New therapeutic perspective 20min Discussion 40min | Session 5| Guidelines for the Management of hyperglycemia in Type 2 Diabetes Chairs: ADA 2026 20min EASD 2026 20min IDF Global Recommendations for Type 2 management 20min Chinese Guidelines 20min Discussion 40min | Session 6| Diabetes Management: news at the horizon Chairs: Overview of International Guidelines for lipids management in diabetes 20min AI in prevention and treatment of obesity and diabetes 20min Can we change theMicrobiome in obesity and diabetes? 20min New insulin in diabetes 20min Discussion 40 min |
May 23 SATURDAY 2026